The measurement of circulating concentrations of GDF15 is beginning to enter clinical practice as a diagnostic biomarker in mitochondrial disease and as a prognostic marker in conditions such as heart failure and certain cancers (Fujita et al., 2016, Wang et al., 2013, Wollert et al., 2017). This evidence concerns the gene GDF15 and cancer.